NCT07864207
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07864207
Title Phase 1/2 Multicenter, Open-label, Dose-escalation Study of IDP- 121 in Patients With Platinum-resistant Small Cell Lung Cancer (MYCrocytic) (MYCrocytic)
Acronym MYCrocytic
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors IDP Discovery Pharma S.L.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.